Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder — Genomics · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Neoplasm of Uncertain Malignant Potential
T-Cell Proliferation of Uncertain Malignant Potential
Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder

Molecular Subtype

Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder

CI-CAN-00000586Explore in graph →

HematologicNon-malignant

NCIt: C7196

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials
Research
Rankings
Sources & provenance

Genomics

Gene alteration frequencies by cohort

Data not yet available

No genomic cohort is mapped to this entity or its descendants. Frequencies come from open-access cohorts (GDC projects) and always carry their denominator (cases profiled); they are never pooled across cohorts.

What CancerIndex knows

Variants & evidence
Genes index